A Randomized Controlled Trial of Vildagliptin Versus Alogliptin: Effective Switch From Sitagliptin in Patients With Type 2 Diabetes

BACKGROUND: We investigated the effects of vildagliptin or alogliptin on blood glucose and hemoglobin A1c (HbA1c) in patients with type 2 diabetes inadequately controlled by sitagliptin. METHODS: In a single-center open-label trial, 35 patients with inadequate glycemic control on sitagliptin therapy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med Res
Hlavní autoři: Shigematsu, Erina, Yamakawa, Tadashi, Oba, Mari S., Suzuki, Jun, Nagakura, Jo, Kadonosono, Kazuaki, Terauchi, Yasuo
Médium: Artigo
Jazyk:Inglês
Vydáno: Elmer Press 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458653/
https://ncbi.nlm.nih.gov/pubmed/28611856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3012w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky